JUNE 3, 2008 — /PRNewswire/ AGAWAM, MA — Microtest Laboratories has doubled its microbial identification and analytical services with the purchase of an additional MicroSeq(R) microbial identification system from Applera Corp.
The MicroSeq is a state-of-the-art DNA sequence-based system that enables Microtest technicians to more quickly and accurately identify bacteria isolates that are not viable or easily identified.
“With the purchase of our second MicroSeq system, we are not only complimenting our existing unit but doubling our analytical capacity and ability to service our clients,” states Dr. Steven Richter, Microtest president and CSO. “As one of the only testing labs in the area with this technology, we are providing our customers with a significant competitive advantage.”
Using the MicroSeq system, Microtest technicians can provide precise and reliable bacteria, mycoplasma, and mold identification in a 24-hour time period. Traditional bacteria and mold identification lab tests are often less accurate and require up to a one-week turnaround time.
“In the highly competitive biotechnology industry, accuracy and speed cannot be compromised,” says Richter. “Our ability to provide rapid identification helps our customers minimize downtime, which directly affects their bottom line. When manufacturing is halted or a cleanroom is shut down and awaiting test results, there is no product going out the door and that translates to an interruption in sales.”
The MicroSeq system is integrated for use across the spectrum of services that Microtest provides. Customers that will benefit most are those that utilize their analytical testing services in:
- Contract manufacturing
- Pharmaceutical testing and validation
- Medical device testing and validation
- Environmental control and testing
- Water validation
- Mold identification
The MicroSeq system is 99 percent reliable with repeatable results and is especially beneficial for companies with pharmaceutical and medical device manufacturing applications.
Microtest is a leader in testing services and contract manufacturing for the medical device, pharmaceutical, and biotechnology industries. Based in Agawam, MA, the company’s expertise and flexible processes enhance product safety and security, accelerate time-to-market, and minimize supply chain disruption.